Asepsis Medical Technologies® is proud to introduce the latest addition to the Calibrated Drug Delivery™ (CCD) platform, the Multi-Dose Safe-2-Dose® syringe. The Multi-Dose Safe-2-
The Safe-T-Syringe® is designed to deliver the highest standard of patient care via parenteral syringe. Its medication calibrated indicia provide enhanced accuracy, convenience and safety through-out preparation and administration.
The multiple indicia correlate one or more recommended doses to individual patient characteristic(s), such a weight or BSA, without any user calculation or correlation to the medication’s instructions. The elimination of these procedures circumvents the sequences responsible for the leading causes of MAE’s during a medicinal injection.
The Safe-T-Syringe® may also provide visually enhanced lower incremental indicia, for ultra-precise preparation and dosing. This design feature is particularly important for small volume and high potency injections.
Additionally, the Safe-T-Syringe® may be marked with a diluent measurement, providing indicia for the exact volume of diluent recommended for the specific medication reconstitution.
Not available in all territories.
The Safe-T-Syringe is a registered trademark of Asepsis Medical Technologies, LLC., and covered by one or more patents, including; U.S. Patent 9,192,723, U.S. Patent 9,302,050, U.S Patent 9,750,883, U.S. Patent 10,857,299 and International Patents; AU2013222819, AU2016269509, AU2018232988, CA2862633, CA3006218, MX351645, MX384,129, JP2015-508321 and Patents Pending.
Asepsis Medical Technologies® is proud to announce their latest Canadian Patent Grant 3,006,218 of August 24, 2021 – for the multi-dose oral Dose-2-Weight Syringe®. The Dose-2-Weight Sy
The Safe-T-Syringe® is designed to deliver the highest standard of patient care via syringe. Its medication calibrated indicia provide enhanced accuracy, convenience and safety through-out preparation
Asepsis Medical Technologies® is proud to introduce the latest addition to the Calibrated Drug Delivery™ (CCD) platform, the Multi-Dose Safe-2-Dose® syringe. The Multi-Dose Safe-2-Dose® syringe provid
Asepsis Medical Technologies announces the U.S. Patent Grant for the Momenta-Dose™ forcé actuated injection device. The Momenta Dose™ is designed to administer rapid small volume subcutaneous or intra
Asepsis announces the patent pending Safe-2-Dose™, the next generation liquid medication dispenser. The caregiver need only unlock the device and squeeze the bottle to obtain the correct amount of med
Asepsis Medical Technologies announces the Australian Patent Acceptance No. 2018232988 for a suction and/or pressure inducing oral medication dosing applicator. The applicator comprising multiple dosi
Asepsis announces the USPTO Notice of Allowance for its second Patent Application for the Safe-T-Fuse™
Asepsis Medical Technologies announces the USPTO issuance of Patent Application Number 15/255,725 for its Safe-T-Fuse™ drug infusion system. The Safe-T-Fuse™ is an industry unique infusion container t